Gain Therapeutics Publicly Traded Corporation
By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding, including lysosomal storage disorders.
%20.jpg)
Headquarters:
United States
Employee Number:
28